Preliminary Program




8.00 - 8.30: Registration and coffee




8.30 - 8.35: Welcome

Leif Groop, Lund University


8.35 - 8.45: Opening Remarks

Olivier Arnaud, JDRF



8.45 - 9.45: Session 1: Major breakthrough in diabetes! What is needed? Views from industry and academia


Chair: Leif Groop, Lund University


2 x 30 min presentations.

- The view from academia. Academia addresses  pharma's wish list and gives its view on what is needed for key advances in diabetes. (Stefano Del Prato, University of Pisa)


- The view from big pharma: Big pharma's great challenges in diabetes research. What we would like from academia in terms of research areas, collaborative efforts etc. (Allan Karlsen, Novo Nordisk)




9.45 – 10.15: Coffee break




10.15 – 11.45: Panel discussion


Can we identify some bottlenecks/gaps that prevent a major breakthrough in diabetes?


Panel members: Henning Beck-Nielsen, University of Southern Denmark; Marc Donath, University Hospital of Basel; Philip Just-Larsen, Sanofi; Allan Karlsen, Novo
Nordisk.




11.45 – 13.15: Lunch and networking




13.15 - 14.15: Session 2: Translation in diabetes: Can we strengthen collaborations?


Chair: Patrick Tricoli, Sanofi


3 x 20 min presentations.


- Open Innovation at Sanofi. (Ulrich Wendt, Sanofi)


- Open Innovation initiative in US. (Stephen Friend, Sage Bionetworks)


- How can biobanks contribute? (Tim Sprosen, University of Oxford)




14.15 - 14.45: Coffee break




14.45 - 15.45: Session 3: What has to happen now? The way forward?


Chair:  Sylvie Bove, Lund University


3 x 20 min presentations.


- Bridging the gap in Germany: Spinnovator and other novel tools to expedite value creation in healthcare (Christian Stein, Ascenion)


- Strategies for capturing regional, national, European and international funding programs for diabetes research (Horst Domdey, BioM Biotech Cluster Development GmbH)


- New financial instruments for technology transfer (Johan Le Men, Inserm Transfert)




15.45 – 17.15: Panel discussion


What are the next steps? Can we propose initiatives with potential to bridge the gaps?


Panel members:  Stephen Friend, Sage Bionetworks;Leif Groop, Lund University; Sven Rohmann, Burrill & Co; Christian Stein, Ascenion; Matthias Tschöp, Helmholtz Zentrum Munich/Teknische Universität Munich.



17.15 – 17.30: Concluding remarks

Olivier Arnaud, JDRF




17.30 – : Networking and buffet




Attendees will be able to feed the panel discussions with comments, ideas, suggestions, questions etc. via a email throughout the meeting.